Get started
Author

Leonor Ribeiro

Observed names: L. Ribeiro, L.A. Ribeiro, Leonor Abreu Ribeiro
Observed institutions: University of Lisbon, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Instituto de Medicina Molecular João Lobo Antunes, Centro Académico de Medicina de Lisboa, Unidade Local de Saúde Santa Maria, CUF Infante Santo Hospital
ORCID: 0000-0002-7657-0902
Observed ORCID: 0000-0002-7657-0902
OpenAlex ID: A5102974245
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
2021 · Joyce O'Shaughnessy, Susana Sousa, et al. · European Journal of Cancer · 89
PDF
HER family in cancer progression: From discovery to 2020 and beyond
2020 · Rakesh Kumar, Bijesh George, et al. · Advances in cancer research · 67
Radiotherapy, Chemotherapy and Immunotherapy—Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma
2022 · Cecília Melo-Alvim, Maria Eduarda Neves, et al. · Diagnostics · 43
PDF
Multiple Primary Malignancies in Head and Neck Cancer: A University Hospital Experience Over a Five-Year Period
2021 · Marta Vaz Batista, João Ulrich, et al. · Cureus · 41
PDF
Prognostic Factors after Liver Resection for Colorectal Liver Metastasis
2015 · Margarida Matias, Mafalda Casa-Nova, et al. · Acta Médica Portuguesa · 25
Targeting Inhibitor of Apoptosis Proteins to Overcome Chemotherapy Resistance—A Marriage between Targeted Therapy and Cytotoxic Chemotherapy
2023 · Tiago Barroso, Cecília Melo-Alvim, et al. · International Journal of Molecular Sciences · 24
PDF
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities
2023 · Miguel Esperança-Martins, Cecília Melo-Alvim, et al. · Cancers · 19
PDF
Pretreatment hemoglobin level as a prognostic factor in patients with locally advanced head and neck squamous cell carcinoma
2020 · Cecília Melo-Alvim, Patrícia Miguel-Semedo, et al. · Reports of Practical Oncology & Radiotherapy · 18
PDF
Organização e implementação de uma consulta de cardio‐oncologia
2016 · Manuela Fiuza, Leonor Ribeiro, et al. · Revista Portuguesa de Cardiologia · 18
PDF
Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): protocol for a 3-arm pragmatic randomized controlled trial
2023 · Eliana V. Carraça, Bruno Rodrigues, et al. · BMC Cancer · 13
PDF
Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response
2025 · Cong Tang, Patrícia Corredeira, et al. · Nature Communications · 11
PDF
165MO Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study
2020 · J. O'Shaughnessy, S. Sousa, et al. · Annals of Oncology · 10
PDF
Prognostic Factors for Patients Treated With Abiraterone
2019 · Cecília M Alvim, André Mansinho, et al. · Future Science OA · 9
Head and neck cancer patient journey’s health literacy: a multidisciplinary team perspective. VOICE study
2024 · Ana Joaquim, Cláudia Vieira, et al. · Supportive Care in Cancer · 8
PDF
Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study
2022 · Manuela Fiuza, Andreia Magalhães, et al. · Revista Portuguesa de Cardiologia · 8
PDF
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
2022 · Diogo Alpuim Costa, José Guilherme Gonçalves Nobre, et al. · Oncology and Therapy · 7
PDF
Effect of Cyclin-Dependent Kinase 4/6 Inhibitors on Circulating Cells in Patients with Metastatic Breast Cancer
2024 · Soraia Lobo-Martins, Patrícia Corredeira, et al. · Cells · 5
PDF
Organization and implementation of a cardio-oncology program
2016 · Manuela Fiuza, Leonor Ribeiro, et al. · Revista Portuguesa de Cardiologia (English Edition) · 5
PDF
Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study
2025 · Joyce O'Shaughnessy, Susana Sousa, et al. · Clinical Breast Cancer · 4
DNA damage targeted therapy for advanced breast cancer
2024 · Vanessa Patel, Sandra Casimiro, et al. · Exploration of Targeted Anti-tumor Therapy · 4
Retrospective study of cisplatin plus radiotherapy toxicities in locally advanced squamous cell carcinoma of the head and neck – ReCisTT study
2024 · Ana Varges Gomes, Gilberto Castro, et al. · Frontiers in Oncology · 3
PDF
Real-World Healthcare Resource Use Associated with Recurrent or Metastatic Head and Neck Cancer Patients Care in Portugal—TRACE Study
2024 · Maria Margarida Teixeira, João Dias, et al. · Current Oncology · 3
80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study
2020 · J. O'Shaughnessy, S.P. Sousa, et al. · Annals of Oncology · 3
PDF
A Collaborative Approach for the Development of a Standardized Set of Patient-Centered Outcomes in Head and Neck Cancers
2023 · Ana Joaquim, Ana Rita Nobre, et al. · Acta Médica Portuguesa · 2
PDF
CDK4/6 Inhibitors-Induced Macrocytosis Is Not Associated with Hemolysis and Does Not Impact Hemoglobin Homeostasis
2025 · Tiago Barroso, Leila Costa, et al. · Cancers · 1
PDF
Works count: 40
Citation count: 529
H-index: 11
I10-index: 13
Year
Topic
Type